These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7638469)

  • 21. The Prostate Cancer Prevention Trial and the future of chemoprevention.
    Thompson IM; Tangen CM; Lucia MS
    BJU Int; 2008 Apr; 101(8):933-4. PubMed ID: 18353157
    [No Abstract]   [Full Text] [Related]  

  • 22. Finasteride for chemoprevention of prostate cancer: why has it not been embraced?
    de Vere White RW
    J Clin Oncol; 2007 Jul; 25(21):2999-3000. PubMed ID: 17634478
    [No Abstract]   [Full Text] [Related]  

  • 23. [Relevance of chemoprevention from PCPT trial].
    Irani J
    Prog Urol; 2008 Apr; 18 Suppl 3():S63-5. PubMed ID: 18455087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemoprevention of prostate cancer. Current status].
    Schmitz-Dräger BJ; Lümmen G; Schäfer RM
    Urologe A; 2007 Jun; 46(6):611-5. PubMed ID: 17483928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoprevention of prostate cancer with finasteride.
    Thompson I; Feigl P; Coltman C
    Important Adv Oncol; 1995; ():57-76. PubMed ID: 7672814
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer.
    Orvieto M; Eggener S
    Eur Urol; 2009 May; 55(5):1073-4. PubMed ID: 19200640
    [No Abstract]   [Full Text] [Related]  

  • 27. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
    Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
    Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of finasteride on risk of prostate cancer: how little we really know.
    Rubin MA; Kantoff PW
    J Cell Biochem; 2004 Feb; 91(3):478-82. PubMed ID: 14755678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer; 2008 Mar; 112(5):1058-65. PubMed ID: 18186497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological approaches to reducing the risk of prostate cancer.
    Rittmaster RS; Fleshner NE; Thompson IM
    Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostatic adenocarcinoma following androgen deprivation therapy: the new difficulty in histologic interpretation.
    Bostwick DG
    Anat Pathol; 1998; 3():1-16. PubMed ID: 10389579
    [No Abstract]   [Full Text] [Related]  

  • 32. The biological basis for the use of an anti-androgen and a 5-alpha-reductase inhibitor in the treatment of recurrent prostate cancer: Case report and review.
    Wang LG; Mencher SK; McCarron JP; Ferrari AC
    Oncol Rep; 2004 Jun; 11(6):1325-9. PubMed ID: 15138573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention of prostate cancer: lessons learned.
    Thompson IM
    BJU Int; 2007 Jul; 100 Suppl 2():15-7. PubMed ID: 17594351
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate cancer: a serious disease suitable for prevention.
    Fitzpatrick JM; Schulman C; Zlotta AR; Schröder FH
    BJU Int; 2009 Apr; 103(7):864-70. PubMed ID: 19302133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hirsutism and acne in hyperandrogenism.
    Moghetti P; Toscano V
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):221-34. PubMed ID: 16772153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Despite positive studies, popularity of chemoprevention drugs increasing slowly.
    Zielinski SL
    J Natl Cancer Inst; 2004 Oct; 96(19):1410-2. PubMed ID: 15467023
    [No Abstract]   [Full Text] [Related]  

  • 37. The finasteride prostate cancer prevention trial (PCPT)--what have we learned?
    Mellon JK
    Eur J Cancer; 2005 Sep; 41(13):2016-22. PubMed ID: 16061372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The PCPT trial].
    Hamdy FC; Rouprêt M
    Prog Urol; 2008 Apr; 18 Suppl 3():S40-3. PubMed ID: 18455082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostate cancer: at the beginning of a new millennium].
    Tombal B; Van Cangh PJ
    Acta Urol Belg; 2000; 68(2):29-33. PubMed ID: 11098584
    [No Abstract]   [Full Text] [Related]  

  • 40. Vitamin E, alpha- and gamma-tocopherol, and prostate cancer.
    Moyad MA; Brumfield SK; Pienta KJ
    Semin Urol Oncol; 1999 May; 17(2):85-90. PubMed ID: 10332921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.